http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016252519-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc11292c0e2be7f32b201e65d49e99cd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369594e2bb6d5868c6695c60d2571998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_286a6fe4df37f7d0918df962e813bc17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48240b51786105ec080b875350607a88
publicationDate 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016252519-A1
titleOfInvention In-vitro method for determining fate of polypeptide variant
abstract The present invention discloses an in-vitro method for determining the fate of protein variants upon administration to a subject. Also provided is a means for establishing comparability between two or more distinct therapeutically effective preparations of the same therapeutic protein.
priorityDate 2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658

Total number of triples: 18.